Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

Anxiolytic Drugs: Benzodiazepines and Buspirone

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

CNS Depressants: Barbiturates and Benzodiazepines

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

Sedatives and Hypnotics: Overview

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[In process].

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2018

Same author

Metabolically healthy and unhealthy weight statuses, health issues and related costs: Findings from the 2013-2015 European Health Examination Survey in Luxembourg.

Diabetes & metabolism·2017

Same author

Core Standards of the EUBIROD Project. Defining a European Diabetes Data Dictionary for Clinical Audit and Healthcare Delivery.

Methods of information in medicine·2015

Same author

Cost of disorders of the brain in Luxembourg.

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2007

Same author

Effect of a previous sprint on the parameters of the work-time to exhaustion relationship in high intensity cycling.

International journal of sports medicine·2005

Same author

Very short (15s-15s) interval-training around the critical velocity allows middle-aged runners to maintain VO2 max for 14 minutes.

International journal of sports medicine·2001

Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026

Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026

Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026

Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026

Same journal

[Climate change and skin].

Revue medicale de Liege·2026

Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2026

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

[Benzodiazepines : known risks and recent data].

J M Cloos¹, V Bocquet

¹Service de Psychiatré, ZithaKlinik, Luxembourg. cloosj@pt.lu

Revue Medicale De Liege

|July 30, 2013

Summary

This summary is machine-generated.

Benzodiazepines, once a preferred treatment for neuropsychiatric disorders, are now viewed with caution due to risks of abuse, dependence, and increased mortality with chronic use. This article reviews benzodiazepine characteristics, risks, and provides guidance on safe usage and withdrawal.

Related Experiment Videos

Last Updated: May 9, 2026

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

Area of Science:

Pharmacology
Neuroscience
Clinical Pharmacy

Context:

Benzodiazepines are widely prescribed for neuropsychiatric conditions.
Their use is increasingly controversial due to safety concerns.
Alternative medications are often preferred.

Purpose:

To review benzodiazepine characteristics available in Belgium.
To detail risks associated with benzodiazepine abuse and dependence.
To highlight risks in specific populations and situations.

Summary:

This article examines various benzodiazepines on the Belgian market.
It discusses potential for abuse and dependence.
New evidence indicates a significantly higher risk of mortality with chronic benzodiazepine use.
Recommendations for rational prescribing and safe withdrawal are provided.

Impact:

Informs healthcare professionals about the risks of benzodiazepines.
Supports evidence-based prescribing practices.
Aids in developing safer patient management strategies for benzodiazepine dependence and withdrawal.